MedAdvisor (ASX:MDR) received a nonbinding letter of intent from a multinational software business with operations in Australia to acquire MedAdvisor's Australia and New Zealand business division in cash, according to a Wednesday Australian bourse filing.
The firm's directors believe the bid to be a materially higher value than what is implied in the current MedAdvisor share price, and it has executed the letter of intent in the best interest of shareholders.
The letter of intent includes customary conditions such as a period of exclusivity to conduct due diligence. The time frame to execute a binding sale and purchase agreement is expected to be around five to seven weeks.
Adelaide Equity Partners and HWL Ebsworth are advising on the potential transaction and are assisting with an ongoing strategic review process.
Its shares soared 30% in recent trading on Wednesday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。